EuBiologics Co

EuBiologics Co EBIT Margin

The EBIT Margin (Operating Margin) of EuBiologics Co (206650.KQ) as of Nov 2, 2026 is 40.66 %. In the previous year, EBIT Margin (Operating Margin) was 26.82 % — a change of 51.62% (higher).

EBIT Margin

40.66 %

YoY

51.62%

Last updated:

EBIT Margin (Operating Margin) of EuBiologics Co is 2025 40.66 % . EBIT Margin (Operating Margin) of EuBiologics Co was 2024 26.82 % . It decreases by 51.62% higher compared to the previous year.

For EuBiologics Co, the operating (EBIT) margin of 40.7% is up versus -20.9% a few years ago.

The EuBiologics Co EBIT Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT Margin
Date
EBIT Margin
Jan 1, 2017
-37.59 KRW
Jan 1, 2018
21.34 KRW
Jan 1, 2019
29.66 KRW
Jan 1, 2020
-20.93 KRW
Jan 1, 2021
-18.36 KRW
Jan 1, 2022
-8.32 KRW
Jan 1, 2024
26.82 KRW
Jan 1, 2025
40.66 KRW
The EuBiologics Co EBIT Margin history
YEAREBIT MarginYoY
40.66 %+51.62%
26.82 %-422.40%
-8.32 %-54.69%
-18.36 %-12.28%
-20.93 %-170.56%
29.66 %+38.98%
21.34 %-156.78%
-37.59 %-73.66%
-142.70 %-15.96%
-169.81 %+188.14%
-58.93 %+6,518.46%
-0.89 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

EuBiologics Co Stock analysis

What does EuBiologics Co do? EuBiologics Co Ltd, headquartered in Seoul, South Korea, operates in the Health Care sector, specializing in biotechnology. The company develops and manufactures biopharmaceutical products, with operations divided into two segments: the Vaccine segment, focusing on oral cholera vaccines, and the Contract Research and Manufacturing Organization (CRMO) segment, providing research and manufacturing services for biopharmaceuticals. Listed on January 24, 2017, EuBiologics employs 323 people. EuBiologics Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about EuBiologics Co stock

EBIT Margin (Operating Margin) of EuBiologics Co is 40.66 % in 2025.

EBIT Margin (Operating Margin) of EuBiologics Co changed from 26.82 % to 40.66 %, representing a 51.62% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBIT Margin (Operating Margin) EuBiologics Co since 2006 – with annual values, charts, and detailed analysis.

EBIT Margin measures operating profitability as a percentage of revenue. It shows how much profit a company makes from operations before interest and taxes.

A 'good' varies by industry and company stage. On Eulerpool, you can compare EBIT Margin (Operating Margin)'s EuBiologics Co with sector peers and the industry average to assess whether it is attractive.

To evaluate EBIT Margin (Operating Margin)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EBIT Margin (Operating Margin).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Margins — EuBiologics Co

Gross MarginEBIT MarginEBITDA MarginNet MarginFCF MarginR&D / RevenueTax RatePayout RatioPre-Tax MarginOCF MarginSGA/RevenueOpEx/RevenueReinvestment Rate

All Key Metrics — EuBiologics Co